GSMA Announces New Speakers for Mobile 360 Series – MENA
The GSMA today announced a number of additional high-profile speakers for its Mobile 360 Series – MENA (Middle East and North Africa) conference taking place on the 26-27 November 2018 in Dubai. The mobile industry-focused event, which is now in its sixth year, will cover the key industry issues facing the region, with a particular emphasis on transformative technologies including artificial intelligence (AI), blockchain and 5G.
“Mobile is having a transformative impact across this diverse region with mobile operators in the GCC states laying the foundations for leadership in 5G and planning ahead to commercial launches, while the region’s emerging markets are seeing rising smartphone adoption,” said John Giusti, Chief Regulatory Officer, GSMA. “We have a incredible line-up of expert speakers this year, ready to outline the key issues and challenges facing the region – we’re looking forward to a thought-provoking and exciting showcase.”
New speakers added to the agenda include:
- Hakam Kanafani, Chairman of the Board, Arab Advisors Group
- Ola Doudin, CEO, BitOasis
- Sandra De Zoysa, Chief Customer Officer, Dialog Sri Lanka
- Saleem Alblooshi, Chief Infrastructure Officer, Du
- Chafic Traboulsi, Regional VP, Head of Networks Middle East, Ericsson
- Khalifa Hassan Al-Forah Al-Shamsi, Group Chief Corporate Strategy and Governance Officer, Etisalat
- Dr. Mohamed Madkour, VP Global Wireless Networks Marketing and Solutions, Huawei
- Ramit Harisinghani, Vice President/Head of MEA, HTC
- Ouassim El Arroussi – Marketing B2B Director, INWI
- Bashar Arafeh, Managing Director, MEA, Irisguard
- Elcin Yanik, EVP Market Development, Mastercard
- Dr. Atef Helmy, Senior Advisor, Board of Directors, Orange Middle East and Africa
- Madhu Dua, Vice President, Reliance Jio
- Dr Homoud Mohammed Alkussayer, Governance and Regulatory Affairs Sector VP, STC
They join previously announced speakers including:
- Hatem Dowidar, CEO International, Etisalat
- Imen Benzine, CMO, Algerie Telecom
- Dr Ling Wu, Chairman, Carrier Blockchain Study Group (CBSG) Consortium
- Osman Sultan, CEO, Du
- Rafiah Ibrahim, President Middle East and Africa, Ericsson
- Mohie Elrafey, CMO, GE Healthcare, Eastern Growth Markets
- Jawad Abbassi, Head of MENA, GSMA
- John Giusti, Chief Regulatory Officer, GSMA
- Anthony Butler, Leader and Chief Technology Officer, IBM Blockchain Services, Middle East and Africa
- Jaime Galviz, COO and CMO, Microsoft MEA
- Thierry Millet, CEO, Orange Tunisia
- Navin Gupta, Managing Director, South Asia and MENA, Ripple
- Daichi Nozaki, VP Global Business, SoftBank
- Nasser bin Suleiman Al-Nasser, CEO, STC
- Ahmed El Beheiry, CEO, Telecom Egypt
- Aysem Ertopuz, EVP Digital Services and Solutions, Turkcell
- Scott Gegenheimer, CEO Operations, Zain Group
Being held at the new location of the Westin Mina Seyahi Hotel in Dubai, the two-day Mobile 360 – MENA will bring together senior-level delegates from across the region to discuss the key developments in the mobile industry and their impact on businesss and citizens across the region. Topics will include cybersecurity risk, digital identity and the Internet of Things, as well as an in-depth focus on the policy and regulatory approaches needed to drive further innovation in the 5G era.
A number of new industry sponsors have recently signed up to support the event, including Telecom Egypt, who have joined as Mobile Partner, alongside Mastercard as Industry Sponsor, Irisgard as Showcase Sponsors and Novation City as Supporting Sponsor. They join previously announced sponsors including Etisalat (Host Sponsor), Huawei (Headline Sponsor), and Ericsson, Facebook, Intelsat and Matrixx Software (Supporting Sponsors).
For further information on Mobile 360 – MENA, including sponsorship opportunities, please visit www.mobile360series.com/mena/. Follow developments and updates on Mobile 360 – MENA (#M360MENA) on Twitter @GSMAEVENTS, on Facebook www.facebook.com/Mobile360Series and LinkedIn on www.linkedin.com/company/gsma-mobile-360-series. Download the event app for further information: www.mobile360series.com/app/.
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.
+971 52 861 4230
GSMA Press Office
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07 | Tiedote
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha
Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58 | Tiedote
Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs
Kalray Joins Autoware Foundation as Founding Premium Member14.12.2018 10:18 | Tiedote
Kalray (Euronext Growth Paris – ALKAL), a pioneer in processors for new intelligent systems, today announced it has joined the Autoware Foundation as a founding premium member. The formation of Autoware was formally announced on December 10, 2018 with a mission of facilitating the deployment of Autoware open-source projects enabling self-driving mobility. The Autoware Foundation creates synergies between corporate development and academic research, enabling autonomous driving technology for everyone. "We are glad to have the presence of Kalray as a premium member of the Autoware Foundation. Having highly efficient hardware solutions supporting autonomous driving software is instrumental to boost the deployment of Autoware in the market!" said Shinpei Kato, member of the Board of Directors for Autoware. Autonomous driving demands massive processing power, low power consumption and bulletproof safety and security to handle critical functions like AI processing, acceleration of perception
IDEMIA Provides Subscription Management Platform to dtac in Thailand to Offer eSIM Connected Watches to All Its Subscribers.14.12.2018 06:30 | Tiedote
IDEMIA, the global leader in Augmented Identity, has been selected by dtac, the leading mobile operator in Thailand, to offer connectivity on eSIM connected watches. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005934/en/ Credits : IDEMIA IDEMIA’s Subscription Management platform (or remote SIM provisioning) is the technology that remotely connects the embedded SIM of a smartwatch to dtac’s network without inserting a physical SIM card. Indeed, the IDEMIA Subscription Manager is a server which securely manages the lifecycle of mobile subscriptions and profiles for eSIM-ready consumer devices and wearables. This solution is compliant with the latest GSMA (Global System for Mobile Communications Association) standards to ensure global interoperability and, thanks to the scalability of the platform, the operator will be able to serve up to millions of customers during peak times. dtac subscribers now have the possibilit
CHMP Grants Positive Opinion for New Indication of Clovis Oncology’s Rubraca®▼ (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer13.12.2018 20:46 | Tiedote
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending an additional indication to include rucaparib as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy. EC approval is anticipated in the first quarter of 2019. Once approved, Rubraca’s indication will expand beyond its initial Marketing Authorization in Europe granted in May 2018 for adult patients with platinum-sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum-based chemotherapy, and who are unable to tolerate further platinum
Dole Food Company Sells Fresh Cut Business in Sweden and Finland13.12.2018 20:00 | Tiedote
Dole Food Company, Inc., announced today an agreement to sell Saba Fresh Cuts AB and Saba Fresh Cuts OY to BAMA International. Saba Fresh Cuts AB—with production facility in Helsingborg Sweden—and Saba Fresh Cuts OY—with production facility in Espoo Finland—are producers of washed and ready-to-eat salads. The companies prepare and sell various fresh-cut salads and vegetables to the retail and foodservice industry in Sweden, Denmark, Finland, Germany and the Baltic States. The sale of Saba Fresh Cuts AB was a necessary condition of the European Commission’s approval of the investment by Total Produce into Dole in July 2018. “I am very pleased with the outcome of this sale in meeting the EU’s requirement,” said Mr. Johan Linden, President and Chief Executive Officer of Dole Food Company, “and I am confident that Saba Fresh Cuts will be in good hands under BAMA’s ownership.” "We are pleased to announce this agreement with Dole for Saba Fresh Cuts. Convenience products and ready-to-eat sal
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme